DH - Definitive Healthcare Corp.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$2.45
DETAILS
HIGH:
$3.50
LOW:
$1.10
MEDIAN:
$2.75
CONSENSUS:
$2.45
UPSIDE:
187.49%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 241.5 | 252.2 | 251.4 | 222.7 | 166.2 | 118.3 | 85.5 |
| Cost of Revenue | 58.2 | 54.7 | 47.5 | 42.6 | 40.7 | 30.5 | 43.0 |
| Gross Profit | 183.3 | 197.5 | 203.9 | 180.0 | 125.5 | 87.8 | 42.5 |
| Operating Expenses | |||||||
| R&D Expenses | 34.8 | 36.5 | 42.4 | 34.9 | 18.6 | 11.1 | 7.4 |
| SG&A Expenses | 133.3 | 133.1 | 153.4 | 141.1 | 89.3 | 48.7 | 37.2 |
| Other Expenses | 35.8 | 738.7 | 337.9 | 48.0 | 45.0 | 44.0 | 0 |
| Operating Expenses | 203.9 | 908.3 | 533.7 | 224.1 | 152.8 | 103.7 | 44.6 |
| Operating Income | |||||||
| Operating Income | (20.6) | (710.8) | (329.8) | (44.0) | (27.3) | (15.9) | (2.2) |
| Interest Expense | 11.3 | 14.8 | 15.2 | 11.2 | 25.9 | 36.5 | 18.4 |
| Interest Income | 7.0 | 14.6 | 13.6 | 2.8 | 0.0 | 0 | 18.4 |
| Profitability | |||||||
| EBITDA | (162.2) | (567.2) | (241.2) | 26.2 | 23.1 | 43.5 | 15.5 |
| EBIT | (198.0) | (618.9) | (293.0) | (30.7) | (36.9) | (16.1) | (18.0) |
| Income Before Tax | (209.3) | (633.7) | (308.2) | (41.9) | (62.8) | (52.6) | (36.4) |
| Income Tax Expense | (10.0) | (42.3) | (18.6) | (17.7) | (0.4) | 0 | 0 |
| Net Income | (138.9) | (413.1) | (202.4) | (7.2) | (51.9) | (52.6) | (36.4) |
| Per Share Data | |||||||
| EPS (Basic) | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 | -0.53 | -0.24 |
| EPS (Diluted) | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 | -0.53 | -0.24 |
| Shares Outstanding | 106.7 | 116.6 | 112.8 | 101.1 | 97.0 | 97.0 | 149.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 163.6 | 105.4 | 131.0 | 146.9 | 387.5 | 24.8 | 8.6 |
| Short-Term Investments | 17.3 | 184.8 | 177.1 | 184.9 | 0 | 0 | 0 |
| Net Receivables | 52.0 | 53.2 | 59.2 | 58.8 | 43.3 | 33.1 | 25.0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 24.7 | 26.8 | 13.1 | 23.1 | 6.9 | 2.9 | 0.8 |
| Total Current Assets | 257.6 | 370.2 | 380.4 | 413.7 | 444.2 | 63.8 | 36.1 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 18.1 | 11.3 | 14.1 | 14.1 | 5.1 | 3.2 | 2.6 |
| Goodwill | 197.2 | 393.3 | 1,075.1 | 1,324.7 | 1,263.1 | 1,261.4 | 1,233.2 |
| Intangible Assets | 247.5 | 297.9 | 323.1 | 350.7 | 352.5 | 410.2 | 446.4 |
| Long-Term Investments | 0 | 0 | 0.5 | 0 | 32.7 | 6.0 | 0 |
| Other Non-Current Assets | 15.1 | 16.7 | 19.2 | 19.3 | 19.9 | 0.5 | 2.7 |
| Total Non-Current Assets | 477.9 | 719.2 | 1,432.0 | 1,708.9 | 1,673.4 | 1,681.5 | 1,685.0 |
| Total Assets | 735.5 | 1,089.4 | 1,825.9 | 2,122.6 | 2,117.6 | 1,745.4 | 1,721.2 |
| Current Liabilities | |||||||
| Account Payables | 3.6 | 10.8 | 5.8 | 3.9 | 4.7 | 5.7 | 2.2 |
| Short-Term Debt | 11.4 | 13.8 | 13.8 | 8.6 | 6.9 | 4.7 | 4.5 |
| Deferred Revenue | 97.0 | 93.3 | 97.4 | 99.7 | 83.6 | 61.6 | 46.0 |
| Other Current Liabilities | 44.8 | 25.2 | 38.7 | 3.2 | 3.0 | 2.1 | 0.3 |
| Total Current Liabilities | 156.8 | 161.2 | 170.7 | 140.6 | 123.1 | 88.7 | 69.9 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 161.2 | 229.4 | 242.6 | 255.8 | 263.8 | 457.2 | 434.8 |
| Deferred Tax Liabilities | 14.6 | 25.1 | 67.2 | 75.7 | 76.4 | 0 | 0 |
| Other Non-Current Liabilities | 16.3 | 59.0 | 136.9 | 158.4 | 154.0 | 3.7 | 0 |
| Total Non-Current Liabilities | 199.7 | 321.0 | 456.0 | 500.1 | 494.7 | 461.1 | 435.0 |
| Total Liabilities | 356.5 | 482.2 | 626.7 | 640.7 | 617.8 | 549.8 | 504.9 |
| Stockholders' Equity | |||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 1,305.5 | 1,272.0 |
| Retained Earnings | (779.5) | (640.6) | (227.4) | (25.1) | (17.8) | (109.9) | (55.8) |
| Accumulated Other Comprehensive Income | (1.4) | (0.6) | 2.1 | 3.7 | 0.1 | (0.1) | 0 |
| Total Stockholders' Equity | 281.1 | 444.4 | 861.4 | 948.9 | 871.3 | 1,195.6 | 1,216.2 |
| Total Liabilities & Equity | 735.5 | 1,089.4 | 1,825.9 | 2,122.6 | 2,117.6 | 1,745.4 | 1,721.2 |
| Debt Metrics | |||||||
| Total Debt | 177.8 | 253.1 | 267.9 | 275.8 | 270.7 | 461.9 | 439.3 |
| Net Debt | 14.2 | 147.7 | 137.0 | 128.9 | (116.8) | 437.1 | 430.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (199.3) | (591.4) | (202.4) | (22.3) | (62.3) | (52.6) | (36.4) |
| Depreciation & Amortization | 56.1 | 51.7 | 51.8 | 56.9 | 59.9 | 59.6 | 33.5 |
| Stock-Based Compensation | 29.1 | 38.1 | 48.7 | 36.4 | 10.0 | 1.7 | 0 |
| Change in Working Capital | (9.4) | (25.9) | (30.4) | (22.0) | (2.5) | (0.1) | 12.4 |
| Other Non-Cash Items | 188.1 | 705.4 | 192.2 | 13.1 | 20.7 | 14.6 | 12.0 |
| Operating Cash Flow | 53.8 | 58.2 | 41.2 | 35.6 | 25.2 | 23.2 | 21.6 |
| Investing Activities | |||||||
| Capital Expenditure | (16.7) | (12.3) | (3.0) | (8.3) | (6.7) | (1.4) | (1.9) |
| Acquisitions | 0 | (13.5) | (45.0) | (56.3) | (40) | (22.5) | (1,138.0) |
| Purchases of Investments | (64.1) | (304.3) | (259.2) | (338.0) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 234.7 | 303.8 | 275.4 | 153.7 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 153.9 | (26.4) | (31.8) | (248.9) | (46.7) | (23.9) | (1,139.9) |
| Financing Activities | |||||||
| Net Debt Issuance | (79.5) | (13.8) | (8.6) | (6.9) | (199.5) | 13.5 | 434.6 |
| Stock Repurchased | (49.5) | (22.4) | 0 | 0 | (231.8) | 0 | 0 |
| Dividends Paid | (3.1) | (5.1) | (12.3) | (12.9) | (8.1) | (2.9) | (7.0) |
| Other Financing Activities | (18.7) | (15.5) | (4.7) | (5.2) | (11.2) | 6.1 | 0 |
| Financing Cash Flow | (150.8) | (56.7) | (25.6) | (26.7) | 384.4 | 16.7 | 1,124.7 |
| Cash Position | |||||||
| Net Change in Cash | 58.2 | (25.6) | (16.0) | (240.6) | 362.7 | 16.2 | 8.6 |
| Cash at Beginning | 105.4 | 131.0 | 146.9 | 387.5 | 24.8 | 8.6 | 0 |
| Cash at End | 163.6 | 105.4 | 131.0 | 146.9 | 387.5 | 24.8 | 8.6 |
| Free Cash Flow | 37.1 | 45.9 | 38.2 | 27.3 | 18.5 | 21.8 | 19.7 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 241.5 | 252.2 | 251.4 | 222.7 | 166.2 | 118.3 | 85.5 |
| Gross Profit | 183.3 | 197.5 | 203.9 | 180.0 | 125.5 | 87.8 | 42.5 |
| Operating Income | (20.6) | (710.8) | (329.8) | (44.0) | (27.3) | (15.9) | (2.2) |
| Net Income | (138.9) | (413.1) | (202.4) | (7.2) | (51.9) | (52.6) | (36.4) |
| EPS (Diluted) | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 | -0.53 | -0.24 |
| Balance Sheet | |||||||
| Cash & Equivalents | 163.6 | 105.4 | 131.0 | 146.9 | 387.5 | 24.8 | 8.6 |
| Total Assets | 735.5 | 1,089.4 | 1,825.9 | 2,122.6 | 2,117.6 | 1,745.4 | 1,721.2 |
| Total Debt | 177.8 | 253.1 | 267.9 | 275.8 | 270.7 | 461.9 | 439.3 |
| Stockholders' Equity | 281.1 | 444.4 | 861.4 | 948.9 | 871.3 | 1,195.6 | 1,216.2 |
| Cash Flow | |||||||
| Operating Cash Flow | 53.8 | 58.2 | 41.2 | 35.6 | 25.2 | 23.2 | 21.6 |
| Capital Expenditure | (16.7) | (12.3) | (3.0) | (8.3) | (6.7) | (1.4) | (1.9) |
| Free Cash Flow | 37.1 | 45.9 | 38.2 | 27.3 | 18.5 | 21.8 | 19.7 |